API Holdings gains 51.02% in Thyrocare via Docon amalgamation
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.1 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
API Holdings merger with Docon Technologies was sanctioned by NCLT on Aug 31, 2026 and became effective Sept 3, 2026. Docon 8,12,00,000 shares (51.02%) in Thyrocare transferred to API Holdings. No change in aggregate promoter group holding of Thyrocare.
Internal promoter restructuring - no change in ultimate promoter control. Existing shareholding pattern of Thyrocare continues unchanged.